Bellevue Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-855,293
Closed -$23.1M 177
2024
Q2
$23.1M Sell
855,293
-662,937
-44% -$17.9M 0.38% 66
2024
Q1
$27.8M Buy
1,518,230
+82,548
+6% +$1.51M 0.42% 68
2023
Q4
$17.6M Buy
1,435,682
+5,120
+0.4% +$62.8K 0.27% 79
2023
Q3
$21.4M Buy
1,430,562
+73,799
+5% +$1.11M 0.35% 72
2023
Q2
$44.1M Buy
1,356,763
+287,024
+27% +$9.33M 0.63% 54
2023
Q1
$41.9M Buy
1,069,739
+57,216
+6% +$2.24M 0.61% 52
2022
Q4
$53.5M Sell
1,012,523
-34,833
-3% -$1.84M 0.71% 44
2022
Q3
$47.1M Buy
1,047,356
+70
+0% +$3.15K 0.68% 46
2022
Q2
$38.1M Buy
1,047,286
+1,719
+0.2% +$62.6K 0.54% 56
2022
Q1
$43.2M Buy
1,045,567
+93,134
+10% +$3.85M 0.5% 63
2021
Q4
$40.6M Buy
952,433
+170,773
+22% +$7.28M 0.42% 73
2021
Q3
$43M Sell
781,660
-512,099
-40% -$28.2M 0.44% 71
2021
Q2
$61.9M Buy
1,293,759
+134,835
+12% +$6.45M 0.6% 55
2021
Q1
$58.7M Buy
1,158,924
+786,034
+211% +$39.8M 0.62% 53
2020
Q4
$23.5M Buy
372,890
+72,271
+24% +$4.55M 0.27% 92
2020
Q3
$20.2M Buy
300,619
+55,281
+23% +$3.72M 0.28% 89
2020
Q2
$10.3M Buy
245,338
+50,755
+26% +$2.13M 0.15% 106
2020
Q1
$6.13M Buy
194,583
+10,687
+6% +$336K 0.12% 109
2019
Q4
$7.43M Buy
183,896
+51,942
+39% +$2.1M 0.12% 104
2019
Q3
$4.29M Buy
131,954
+5,144
+4% +$167K 0.08% 114
2019
Q2
$6.15M Buy
+126,810
New +$6.15M 0.1% 104